Former New Taipei City mayor Eric Chu (朱立倫) recently asked what the Democratic Progressive Party (DPP) found so attractive about local biotechnology company Medigen Biologics, even going so far as to mock former vice president Chen Chien-jen (陳建仁) for volunteering to participate in clinical trials for the firm’s COVID-19 vaccine and President Tsai Ing-wen (蔡英文) for promoting the jab.
It is strange that, while the DPP is protecting and supporting the biotech industry, the Chinese Nationalist Party (KMT) seems to be trying to hobble it.
In 2011, when the KMT conjured up controversy over Yu Chang Biologics — with then-KMT legislators Alex Tsai (蔡正元) and Chiu Yi (邱毅) verbally attacking Taiwanese-American researcher David Ho (何大一), who in 1996 appeared on the cover of Time magazine for his work on developing an AIDS drug cocktail that saved the lives of many — then-president Ma Ying-jeou (馬英九) accused Tsai, at the time the DPP’s presidential candidate, of profiteering.
Then-Council for Economic Planning and Development minister Christina Liu (劉憶如) even doctored documents to implicate Tsai.
The Special Investigations Division closed the case in 2012, saying that it found no evidence of wrongdoing, although a civil ruling asked Liu to pay Tsai NT$2 million (US$72,067 at the current exchange rate) in compensation.
Ho said that in mishandling the affair, the Ma administration essentially killed its own offspring, adding that if his country did not welcome him, he was prepared to look elsewhere to realize his biotechnology ambitions.
The KMT single-handedly chased a world-renowned scientist out of the country.
In March 2016, just prior to the transfer of power to the DPP, the KMT initiated the OBI Pharma case, accusing then-Academia Sinica president Wong Chi-huey (翁啟惠) of insider trading, bribery and corruption.
The case was dragged through the courts for years, before it was withdrawn by the Taipei District Prosecutors’ Office and the Taiwan High Prosecutors’ Office, citing insufficient evidence, which resulted in not-guilty verdicts by the Shilin District Court and the Taiwan High Court.
Nevertheless, Wong declined to be considered for the 2016 Nobel Prize in Chemistry, mindful of the damage the case had caused to his reputation.
The KMT hurt Taiwan again by burying the opportunity for the nation to have a Nobel Prize laureate.
After coming up against the KMT’s political machinations, Taiwan’s biotech sector has found itself cash-strapped and bereft of some outstanding scientists who are unwilling to return to these shores.
CommonWealth Magazine in October last year reported that South Korea’s biotech industry had largely contributed to the country’s GDP per capita increase, surpassing Taiwan as leader in the sector.
With the KMT doing its best to hold back Taiwan’s biotech sector, the nation’s biggest rival in the field, South Korea, has continued to develop, and last week Samsung announced it would invest an additional NT$5.76 trillion in the semiconductor and biotech industries.
Fresh out of jail, Samsung Group chairman Jay Y. Lee was given the blessing of the South Korean government to once more take the reins at the company.
Why is Taiwan so ready to see talent and scientists become embroiled in political games? What exactly does the KMT have against Taiwan’s biotech sector?
Liou Je-wei is a graduate student of political science at National Taiwan University.
Translated by Paul Cooper
Recently, China launched another diplomatic offensive against Taiwan, improperly linking its “one China principle” with UN General Assembly Resolution 2758 to constrain Taiwan’s diplomatic space. After Taiwan’s presidential election on Jan. 13, China persuaded Nauru to sever diplomatic ties with Taiwan. Nauru cited Resolution 2758 in its declaration of the diplomatic break. Subsequently, during the WHO Executive Board meeting that month, Beijing rallied countries including Venezuela, Zimbabwe, Belarus, Egypt, Nicaragua, Sri Lanka, Laos, Russia, Syria and Pakistan to reiterate the “one China principle” in their statements, and assert that “Resolution 2758 has settled the status of Taiwan” to hinder Taiwan’s
Singaporean Prime Minister Lee Hsien Loong’s (李顯龍) decision to step down after 19 years and hand power to his deputy, Lawrence Wong (黃循財), on May 15 was expected — though, perhaps, not so soon. Most political analysts had been eyeing an end-of-year handover, to ensure more time for Wong to study and shadow the role, ahead of general elections that must be called by November next year. Wong — who is currently both deputy prime minister and minister of finance — would need a combination of fresh ideas, wisdom and experience as he writes the nation’s next chapter. The world that
Can US dialogue and cooperation with the communist dictatorship in Beijing help avert a Taiwan Strait crisis? Or is US President Joe Biden playing into Chinese President Xi Jinping’s (習近平) hands? With America preoccupied with the wars in Europe and the Middle East, Biden is seeking better relations with Xi’s regime. The goal is to responsibly manage US-China competition and prevent unintended conflict, thereby hoping to create greater space for the two countries to work together in areas where their interests align. The existing wars have already stretched US military resources thin, and the last thing Biden wants is yet another war.
Since the Russian invasion of Ukraine in February 2022, people have been asking if Taiwan is the next Ukraine. At a G7 meeting of national leaders in January, Japanese Prime Minister Fumio Kishida warned that Taiwan “could be the next Ukraine” if Chinese aggression is not checked. NATO Secretary-General Jens Stoltenberg has said that if Russia is not defeated, then “today, it’s Ukraine, tomorrow it can be Taiwan.” China does not like this rhetoric. Its diplomats ask people to stop saying “Ukraine today, Taiwan tomorrow.” However, the rhetoric and stated ambition of Chinese President Xi Jinping (習近平) on Taiwan shows strong parallels with